SCHEMBL1065625

SCHEMBL1065625

Cc1c(C(=O)O)oc2ccc(CBr)cc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 2/20 0.61
KDM4E B2RXH2 2/20 0.58
ALDH1A1 P00352 6/20 0.54
GPR35 Q9HC97 1/20 0.54
HPGD P15428 4/20 0.53
GAA P10253 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
NPSR1 Q6W5P4 1/20 0.53
TSHR P16473 1/20 0.52
NR1H4 Q96RI1 1/20 0.50
RAB9A P51151 2/20 0.48
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
RECQL P46063 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
LMNA P02545 1/20 0.46
HTT P42858 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL937858 0.85 MCL1 (0.58) MCL1KDM4EALDH1A1GPR35HPGD
SCHEMBL2551841 0.84 MCL1 (0.57) MCL1KDM4EALDH1A1GPR35HPGD
SCHEMBL8700102 0.84 MCL1 (0.60) MCL1KDM4EALDH1A1GPR35HPGD
SCHEMBL3617512 0.80 MCL1 (0.67) MCL1KDM4EALDH1A1GPR35HPGD
SCHEMBL7339528 0.79 KDM4E (0.55) MCL1KDM4EALDH1A1GPR35HPGD
SCHEMBL1065472 0.79 MCL1 (0.71) MCL1KDM4EALDH1A1GPR35HPGD
SCHEMBL5287590 0.78 MCL1 (0.69) MCL1KDM4EALDH1A1GPR35HPGD
SCHEMBL4615856 0.76 MCL1 (1.00) MCL1KDM4EALDH1A1GPR35HPGD
SCHEMBL4310466 0.76 MCL1 (0.67) MCL1KDM4EALDH1A1GPR35HPGD
SCHEMBL10952726 0.75 NPC1 (0.57) MCL1KDM4EALDH1A1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7868204-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2011-01-11 US disclosed
US-7595343-B2 Inhibitors of histone deacetylase METHYLGENE, INC. (CA) 2009-09-29 US disclosed
US-20050288282-A1 Inhibitors of histone deacetylase METHYLGENE, INC. 2005-12-29 US disclosed
EP-1590340-A1 INHIBITORS OF HISTONE DEACETYLASE Methylgene, Inc. (CA) 2005-11-02 EP disclosed
US-6897220-B2 Inhibitors of histone deacetylase METHYLGENE, INC. (CA) 2005-05-24 US disclosed
WO-2004069823-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE, INC. (CA) 2004-08-19 WO disclosed
US-20040142953-A1 Inhibitors of histone deacetylase METHYLGENE, INC. 2004-07-22 US disclosed
EP-1429765-A2 INHIBITORS OF HISTONE DEACETYLASE Methylgene, Inc. (CA) 2004-06-23 EP disclosed
US-20040106599-A1 Inhibitors of histone deacetylase 92229129 QUEBEC INC. (CA) 2004-06-03 US disclosed
WO-2003024448-A2 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE, INC. (CA) 2003-03-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288282-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC3 MCL1 262/4885KDM4E 123/4885ALDH1A1 796/4885
US-20040106599-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC3 MCL1 262/4885KDM4E 123/4885ALDH1A1 796/4885
US-20040142953-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC3 MCL1 262/4885KDM4E 123/4885ALDH1A1 796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.